tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Abivax SA (GB:0RA9)
LSE:0RA9
UK Market
0RA9
Abivax SA
RESEARCH TOOLSreports

Abivax SA (0RA9) Stock News & Sentiment

Compare
0 Followers
0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12d ago
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
Premium
Ratings
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
15d ago
ABVX
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
Premium
Ratings
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
21d ago
ABVX
Positive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating
Premium
Ratings
Positive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating
2M ago
ABVX
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
Premium
Ratings
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
3M ago
ABVX
Promising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
Premium
Ratings
Promising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
3M ago
ABVX
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
Premium
Ratings
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
4M ago
ABVX
More GB:0RA9 News >

0RA9 News on the Web

European markets open in negative territory ahead of short trading week
CNBC
Neutral
ABIVAX (ENXTPA:ABVX) Q3 2025 Loss Surges to €153m, Reinforcing Cash-Burn Concerns
Simply Wall St
Neutral
Europe's best performing stock is up 1,400% this year. Here's what next
CNBC
Neutral
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)
TipRanks News
Neutral
Is Obefazimod’s Phase 3 UC Success Reshaping The Investment Case For ABIVAX (ENXTPA:ABVX)?
Simply Wall St
Neutral
European markets to open higher as choppy month draws to an end
CNBC
Neutral
Assessing Abivax (ENXTPA:ABVX) Valuation Following Phase 3 Patient-Reported Outcomes for Obefazimod in Ulcerative Colitis
Simply Wall St
Bullish
Did Positive Phase 3 Obefazimod Data Just Shift ABIVAX Société Anonyme's (ENXTPA:ABVX) Investment Narrative?
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
GB:0RA9
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0RA9’s Media Buzz Sentiment?
1 articles about GB:0RA9 were published this week. In an average week, 1.5 articles are published.
    What is GB:0RA9’s weekly average amount of articles?
    In an average week, 1.5 articles about GB:0RA9 are published.
      What is GB:0RA9’s News Sentiment?
      50% of articles about GB:0RA9 were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        ATAIATAI Life Sciences
        ADUSAddus Homecare
        DVAXDynavax
        PDEXPro-Dex
        AGIOAgios Pharma
        Showing the stocks with the most bullish news sentiment over the past week